Connecting you to content on EBSCOhost

Works matching IS 10685308 AND DT 2024 AND VI 35 AND IP 1

Results: 11

1

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 9, doi. 10.1002/pu.31115
Publication type:: Article

2

Approval.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 8, doi. 10.1002/pu.31114
Publication type:: Article

3

Research suggests antidepressant benefit of GLP‐1 receptor agonists.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 8, doi. 10.1002/pu.31113
Publication type:: Article

4

Orexin receptor agonist improves outcomes in narcolepsy, but with liver effects.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 6, doi. 10.1002/pu.31112
Publication type:: Article

5

Cannabis use associated with poor mental health outcomes.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 6, doi. 10.1002/pu.31111
Publication type:: Article

6

The Age of Aquarius revisited: implications of a new psychedelic era.

Published in:

Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 7, doi. 10.1002/pu.31110

By:

Price, Lawrence H.

Publication type:

Article

7

Gradual reduction of antipsychotic dosing increased relapse with no benefit in social functioning.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 4, doi. 10.1002/pu.31109
Publication type:: Article

8

Esketamine augmentation superior to quetiapine augmentation in treatment‐resistant depression.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 3, doi. 10.1002/pu.31108
Publication type:: Article

9

Clozapine‐associated myocarditis.

Published in:

Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 2, doi. 10.1002/pu.31107

By:

Lam, Y. W. Francis

Publication type:

Article

10

Study finds comparatively few long‐term and high‐dose users of benzodiazepines.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 1, doi. 10.1002/pu.31106
Publication type:: Article

11

MDMA‐assisted therapy for PTSD reduced symptoms in Phase 3 trial.

Published in:: Brown University Psychopharmacology Update, 2024, v. 35, n. 1, p. 1, doi. 10.1002/pu.31105
Publication type:: Article